RecruitingNCT05826457

North American Prodromal Synucleinopathy Consortium Stage 2


Sponsor

Washington University School of Medicine

Enrollment

500 participants

Start Date

Aug 12, 2022

Study Type

OBSERVATIONAL

Conditions

Summary

This study will enroll participants with idiopathic REM sleep behavior disorder (RBD) and healthy controls for the purpose of preparing for a clinical trial of neuroprotective treatments against synucleinopathies.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is following people who have REM sleep behavior disorder — a condition where people physically act out their dreams while sleeping — because this condition can be an early warning sign of Parkinson's disease or a related brain disorder. The study also enrolls healthy matched controls for comparison. **You may be eligible if...** - You are over 18 years old - You have been diagnosed with REM sleep behavior disorder (confirmed by a sleep study) - OR you are a healthy volunteer matched by age, sex, and race to someone with REM sleep behavior disorder - You are willing to undergo brain imaging and a lumbar puncture (spinal fluid test) **You may NOT be eligible if...** - You already have a diagnosis of Parkinson's disease, dementia, or multiple system atrophy (unless you previously participated in the first stage of this study) - You have narcolepsy - You have an active psychiatric or medical condition that would make participation unsafe - You have a contraindication to MRI or lumbar puncture Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(9)

University of California Los Angeles

Los Angeles, California, United States

Stanford University

Redwood City, California, United States

Emory University

Atlanta, Georgia, United States

Massachusetts General Hospital

Boston, Massachusetts, United States

University of Minnesota

Minneapolis, Minnesota, United States

Mayo Clinic Rochester

Rochester, Minnesota, United States

Washington University School of Medicine

St Louis, Missouri, United States

Oregon Health Sciences University

Portland, Oregon, United States

McGill University Health Centre Research Institute

Montreal, Quebec, Canada

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05826457


Related Trials